Glenmede Trust’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-82,871
Closed -$6.64M 2838
2016
Q4
$6.64M Sell
82,871
-1,125
-1% -$89.3K 0.04% 425
2016
Q3
$6.7M Sell
83,996
-4,707
-5% -$380K 0.04% 427
2016
Q2
$6.92M Sell
88,703
-110,137
-55% -$7.85M 0.04% 408
2016
Q1
$10.9M Buy
198,840
+156,859
+374% +$8.55M 0.07% 335
2015
Q4
$2.59M Sell
41,981
-173,513
-81% -$10.9M 0.02% 548
2015
Q3
$13.6M Buy
215,494
+44,333
+26% +$3.16M 0.1% 299
2015
Q2
$12.5M Buy
171,161
+14,775
+9% +$1.07M 0.09% 320
2015
Q1
$10.2M Buy
156,386
+126,300
+420% +$8.4M 0.07% 351
2014
Q4
$1.96M Sell
30,086
-2,729
-8% -$176K 0.02% 579
2014
Q3
$1.97M Sell
32,815
-83,626
-72% -$5.46M 0.02% 554
2014
Q2
$8.06M Buy
116,441
+5,221
+5% +$338K 0.07% 345
2014
Q1
$7.27M Buy
111,220
+3,046
+3% +$198K 0.07% 361
2013
Q4
$6.7M Buy
108,174
+10,564
+11% +$612K 0.07% 335
2013
Q3
$5.23M Buy
97,610
+19,681
+25% +$1.01M 0.06% 350
2013
Q2
$3.55M Buy
+77,929
New +$3.38M 0.04% 403

Other funds holding STJ

Glenmede Trust's STJ Position: Q1 2017 in Review

Glenmede Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 82,871 shares — an estimated $6.64M sold.

Glenmede Trust first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $13.6M in Q3 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Glenmede Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 82,871 St Jude Medical shares in Q1 2017, an estimated $6.64M.
  • Glenmede Trust first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Glenmede Trust's St Jude Medical position peaked at $13.6M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.